GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Verano Holdings Corp (OTCPK:VRNOF) » Definitions » EBIT

Verano Holdings (Verano Holdings) EBIT : $87.6 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Verano Holdings EBIT?

Verano Holdings's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2023 was $-18.2 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was $87.6 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Verano Holdings's annualized ROC % for the quarter that ended in Dec. 2023 was 14.97%. Verano Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -12.18%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Verano Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 4.43%.


Verano Holdings EBIT Historical Data

The historical data trend for Verano Holdings's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verano Holdings EBIT Chart

Verano Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
-0.06 89.89 73.26 -113.97 87.59

Verano Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -201.29 34.99 28.63 42.20 -18.23

Competitive Comparison of Verano Holdings's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Verano Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Verano Holdings's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Verano Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Verano Holdings's EV-to-EBIT falls into.



Verano Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $87.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Verano Holdings  (OTCPK:VRNOF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Verano Holdings's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

ROC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=127.628 * ( 1 - -134.66% )/( (2016.244 + 1986.304)/ 2 )
=299.4918648/2001.274
=14.97 %

where

Invested Capital(Q: Sep. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2355.103 - 336.155 - ( 129.921 - max(0, 352.3 - 355.004+129.921))
=2016.244

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2318.745 - 350.433 - ( 174.76 - max(0, 412.188 - 394.196+174.76))
=1986.304

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Verano Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-72.908/( ( (602.874 + max(-111.072, 0)) + (594.763 + max(-130.997, 0)) )/ 2 )
=-72.908/( ( 602.874 + 594.763 )/ 2 )
=-72.908/598.8185
=-12.18 %

where Working Capital is:

Working Capital(Q: Sep. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(34.315 + 150.821 + 39.947) - (336.155 + 0 + 5.6843418860808E-14)
=-111.072

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(38.981 + 140.687 + 39.768) - (350.433 + 0 + 0)
=-130.997

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Verano Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2023 )
=87.592/1976.731
=4.43 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Verano Holdings EBIT Related Terms

Thank you for viewing the detailed overview of Verano Holdings's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Verano Holdings (Verano Holdings) Business Description

Traded in Other Exchanges
Address
415 North Dearborn Street, 4th Floor, Chicago, IL, USA, 60654
Verano Holdings Corp is a vertically integrated multi?state cannabis operator in the United States. The company derives its revenues from its wholesale business and its retail dispensary chains. The retail business includes the design, build-out and operation of branded dispensaries in both medical and adult-use markets. The company's consumer brands include Encore, Avexia, MÜV, Savvy, BITS and Verano. The company's retail dispensaries operate under brands including Zen Leaf and MÜV.